Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health Response topic

No spam. Unsubscribe anytime.

Health committee asks what would trigger local action on cyclospora; expert cites establishment link, clusters, hospitalizations

Board of Legislators Committee on Health · August 5, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Committee members asked what would prompt Westchester to act; Dr. Gary Zeatland said links to a specific food establishment, a local cluster or hospitalization patterns should trigger further investigation, and noted two deaths reported nationwide and modest local caseloads.

Members of the Westchester County Board of Legislators’ health committee pressed an infectious-disease expert on what would prompt stronger local public-health action around cyclospora.

Dr. Gary Zeatland said evidence tying cases to a specific retail or restaurant location, identification of a local cluster, or a rise in hospitalizations should trigger more aggressive local investigation and response. He told the panel his “understanding is there were 2 deaths” nationwide connected to the outbreak, and that White Plains Hospital’s caseload at the time remained in the single digits while county totals were higher than the prior year but did not represent a major local spike.

Committee members asked whether local labs and clinicians are positioned to detect and follow up on clusters; Dr. Zeatland said many clinicians are using GI pathogen panels and that turnaround varies by facility, with White Plains Hospital typically returning results within 24 hours. He said CDC and local health departments are investigating multiple genotypic clusters and that, because molecular data for cyclospora can be limited, epidemiologic links to food items are important signals for follow-up.

The committee did not vote on new authorities or mandates at the meeting; the discussion emphasized surveillance, clinician testing awareness and communicating targeted prevention guidance to higher-risk residents.